causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance the ...
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated HUB ...
The companies initially partnered to execute advanced causal AI models to optimize commercial programs, pivoting from time-intensive data science tools to faster, AI-driven decision-making to speed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results